Trump’s Leverage Pays Off: AstraZeneca Signs Historic Price Deal

The Second Big Win in Two Weeks

On Friday, President Donald Trump scored another major victory in his quest to meet his campaign promise to make prescription drugs affordable for Americans.

Advertisement

AstraZeneca joined Pfizer in agreeing to lower U.S. prices, matching those charged in other developed nations. Friday’s deal marks the second major agreement in as many weeks, signaling that Trump’s brand of economic pressure, which he calls “America First Negotiation,” forces Big Pharma to reconsider its pricing model.

Trending: HILARIOUS! They Just Made Another One!

Under this agreement, AstraZeneca extends “most favored nation” pricing to every state’s Medicaid program, meaning U.S. taxpayers won’t pay more than countries such as Germany, Canada, or Japan for the same medications.

The company plans to participate

Continue reading